Frontier Capital Management’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$482K Hold
8,251
– – 0.01% 283
2026
Q2
$463K Buy
8,251
+181
+2% +$9.42K ﹤0.01% 284
2026
Q1
$387K Hold
8,070
– – ﹤0.01% 278
2025
Q4
$312K Buy
+8,070
New +$308K ﹤0.01% 285

Other funds holding RPRX

Frontier Capital Management's RPRX Position: Q3 2026 in Review

Frontier Capital Management held its Royalty Pharma (RPRX) position steady in Q3 2026 at 8,251 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #283.

Frontier Capital Management first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 702 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Frontier Capital Management held 8,251 shares of Royalty Pharma worth $482K as of Q3 2026.
  • Frontier Capital Management left its Royalty Pharma share count unchanged in Q3 2026.
  • Royalty Pharma made up 0.01% of Frontier Capital Management's portfolio in Q3 2026, its #283 holding.
  • Frontier Capital Management first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • 702 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Frontier Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.